Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Theranostic”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Not applicableLooking for participantsNCT06550687
What this trial is testing

Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.

Who this might be right for
All Types of Metastatic Solid Malignancy1st-line TreatmentExome Analysis+1 more
Centre Georges Francois Leclerc 80
Testing effectiveness (Phase 2)Study completedNCT03936426
What this trial is testing

Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™

Who this might be right for
Meningioma
Clarity Pharmaceuticals Ltd 5
Not applicableStudy completedNCT01949285
What this trial is testing

Transcutaneous Electrical Spinal Cord Stimulation for Lower Limbs

Who this might be right for
Spinal Cord Injury
NeuroEnabling Technologies, Inc. 10
Not applicableStudy completedNCT04690920
What this trial is testing

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Who this might be right for
Corona Virus Disease 2019 (COVID-19)
University of Lahore 200
Testing effectiveness (Phase 2)Looking for participantsNCT06726161
What this trial is testing

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
RayzeBio, Inc. 590
Testing effectiveness (Phase 2)Looking for participantsNCT06955169
What this trial is testing

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Who this might be right for
Intracranial Meningioma
RTOG Foundation, Inc. 130
Testing effectiveness (Phase 2)Study completedNCT05889728
What this trial is testing

Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer

Who this might be right for
Breast Cancer
St Vincent's Hospital, Sydney 20
Early research (Phase 1)Looking for participantsNCT06228482
What this trial is testing

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Who this might be right for
Metastatic Nonsmall Cell Lung Cancer
University of California, Davis 40
Early research (Phase 1)Study completedNCT04904120
What this trial is testing

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Who this might be right for
Melanoma (Skin)Melanoma Stage IVMelanoma, Uveal+1 more
Perspective Therapeutics 7
Early research (Phase 1)Not Yet RecruitingNCT06941480
What this trial is testing

177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Who this might be right for
Neuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT02777489
What this trial is testing

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects

Who this might be right for
Obesity
Gene PreDiT 140
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Not applicableStudy completedNCT05798273
What this trial is testing

(68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors

Who this might be right for
Malignant Brain Tumors
Erasmus Medical Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06066437
What this trial is testing

NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 6
Early research (Phase 1)Looking for participantsNCT07688187
What this trial is testing

Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
PeptiDream Inc. 60
Early research (Phase 1)Study completedNCT03246659
What this trial is testing

Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC

Who this might be right for
Medullary Thyroid Carcinoma
Paola Anna Erba 16
Testing effectiveness (Phase 2)Temporarily pausedNCT06200103
What this trial is testing

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 236
Not applicableLooking for participantsNCT07045571
What this trial is testing

MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmPancreas Cancer
Yingbin Liu, MD, PhD, FACS 1,000
Not applicableLooking for participantsNCT05547919
What this trial is testing

PSMA in Gastroenterologic Tumors (GIPSMA)

Who this might be right for
Gastrointestinal Cancer
Wuerzburg University Hospital 46
Testing effectiveness (Phase 2)Study completedNCT03392428
What this trial is testing

A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Cancer of the ProstateMetastatic Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 201
Next Page